Schedule of Warrant Activity (Details) - Warrant [Member] - shares |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2025 |
Dec. 31, 2024 |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
| Number of shares, outstanding, beginning balance | 1,359,375 | |
| Weighted average exercise price per share, outstanding, beginning balance | 0.80 | |
| Weighted average remaining life (years), outstanding | 6 months 3 days | 11 months 4 days |
| Number of shares, granted | ||
| Weighted average exercise price per share, granted | ||
| Number of shares, forfeited | ||
| Weighted average exercise price per share, forfeited | ||
| Number of shares, outstanding, ending balance | 1,359,375 | 1,359,375 |
| Weighted average exercise price per share, outstanding, ending balance | 0.80 | 0.80 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments weighted average exercise price per share. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments weighted average exercise price per share forfeited. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments weighted average exercise price per share granted. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments weighted average remaining life. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|